Keros Therapeutics Inc
KROSInsider trades and stock quote 2023-2025
All insider trades at Keros Therapeutics Inc
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 4/9/2025 | Buy | Adar1 Capital Management, LLC | Ten Percent Owner | $9.9 | $9,464,512 |
| 8/13/2024 | Sell | Orbimed Advisors LLC | Director | $44.0 | $11,002,500 |
| 8/13/2024 | Sell | Gordon, Carl L. | Director | $44.0 | $11,002,500 |
| 1/4/2024 | Sell | Regnante, Keith | CHIEF FINANCIAL OFFICER | $45.3 | $1,811,600 |
| 11/4/2023 | Sell | Regnante, Keith | Chief Financial Officer | $45.3 | $1,811,600 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)